FDA moves to facilitate personalized therapies for rare diseases
Source: Washington Examiner · Bias: Center Right
Summary
The Food and Drug Administration is making it possible for pharmaceutical companies to produce bespoke medicines for individual patients, an effort to revolutionize the standard of care for rare diseases. Trump administration officials announced on Monday new draft guidance from the FDA that would update approval standards for personalized genetic medicines, creating a new approval […]
Related Coverage
- Rare ‘Exeter’ copy of Declaration of Independence discovered in UK (Center — The Hill News)
- Rare copy of US Declaration of Independence found by volunteer in UK archives (Center — BBC News)
- MAGA world shrugs as Trump reports $2.2 billion in personal gains (Far Left — Raw Story)
- MAGA Base Stays Quiet After Trump Reports Billions in Personal Gains (Center Left — NYT > U.S. > Politics)
- Rare copy of Declaration of Independence found by UK National Archives in papers of captured US ship (Right — New York Post)
- DOJ Accidentally Gives Jack Smith Report to Person They’re Suing (Left — The New Republic)
- ‘Birth tourism,’ though rare, prompts talk of barring pregnant women from entering US (Center — The Hill News)
- US moves to eliminate long-time radiation safety principle for nuclear power (Center — The Hill News)
More Headlines From February 23, 2026
- The Supreme Court Makes a Prudent Ruling on the Trump Tariffs (Center Right)
- Conservative National Review blasts 'angry toddler' Trump over Supreme Court attack (Left)
- Trump fumes at 'fake news' after 3 separate reports reveal general’s White House warning (Left)
- Top general warns White House as 'ongoing debate' consumes Trump’s 'brain trust' (Left)
- US women's hockey team won't visit Trump's White House (Left)








